:: Volume 21, Issue 3 (6-2023) ::
Int J Radiat Res 2023, 21(3): 605-608 Back to browse issues page
Isolated scapular metastasis from breast carcinoma
H. Baysal , B. Baysal , M. Tarik Tatoglu , O. Alimoglu
Istanbul Medeniyet University Goztepe Prof. Dr. Suleyman Yalcin City Hospital, General Surgery, Istanbul, Turkey , hakanbaysal_tr@yahoo.com
Abstract:   (939 Views)
Breast cancer is the most common cancer in women and the most common cause of cancer-related death in women worldwide. Distant metastases in breast cancer occur in the bones, lungs, liver, and brain. Surgical treatment is recommended because the resection of primary tumor in breast cancer has a positive effect on prognosis and survival. The importance of ablative therapy has increased with the development of systemic treatments for a small number of organ metastases, which are referred to as oligometastases. Patients with isolated bone metastases have better prognosis than those with other visceral metastases. In single bone metastases, systemic and local treatments are preferred using a multidisciplinary approach. This case report presents a breast cancer patient with contralateral isolated scapula glenoid metastases, which have not been reported in the literature.
Keywords: Breast cancer, metastases, scapula.
Full-Text [PDF 786 kb]   (794 Downloads)    
Type of Study: Case Report | Subject: Radiation Biology
References
1. 1. Riggio AI, Varley KE, Welm AL (2021) The lingering mysteries of metastatic recurrence in breast cancer. British Journal of Cancer, 124(1): 13-26. [DOI:10.1038/s41416-020-01161-4] [PMID] []
2. Wang R, Zhu Y, Liu X, Liao X, He J, Niu L (2019) The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer, 19(1): 1091. https://doi.org/10.21203/rs.2.11765/v4 https://doi.org/10.21203/rs.2.11765/v3 https://doi.org/10.21203/rs.2.11765/v2 https://doi.org/10.21203/rs.2.11765/v1 [DOI:10.1186/s12885-019-6311-z]
3. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website, April 2018.
4. Pulido C, Vendrell I, Ferreira AR, Casimiro S, Mansinho A, Alho I, et al. (2017) Bone metastasis risk factors in breast cancer. Ecancermedicalscience, 11: 715. [DOI:10.3332/ecancer.2017.715] [PMID] []
5. Harris E, Barry M, Kell MR (2013) Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival. Annals of surgical oncology, 20(9): 2828-2834. [DOI:10.1245/s10434-013-2998-2] [PMID]
6. Song X, Wei C, Li X (2022) The Signaling Pathways Associated With Breast Cancer Bone Metastasis. Front Oncol, 12: 855609. [DOI:10.3389/fonc.2022.855609] [PMID] []
7. Wu X, Li F, Dang L, Liang C, Lu A, Zhang G (2020) RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies. Frontiers in Cell and Developmental Biology, 8: 76. [DOI:10.3389/fcell.2020.00076] [PMID] []
8. Marazzi F, Orlandi A, Manfrida S, Masiello V, Di Leone A, Massaccesi M, et al. (2020) Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians. Cancers, 12(9): 2390. [DOI:10.3390/cancers12092390] [PMID] []
9. Clézardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, et al. (2021) Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 101(3): 797-855. [DOI:10.1152/physrev.00012.2019] [PMID]
10. Wang L, Fang D, Xu J, Luo R (2020) Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review. BMC Cancer, 20(1): 1059. [DOI:10.1186/s12885-020-07568-9] [PMID] []
11. van der Velden J, Willmann J, Spałek M, Oldenburger E, Brown S, Kazmierska J, et al. (2022) ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases. Radiother Oncol. 173: 197-206. [DOI:10.1016/j.radonc.2022.05.024] [PMID]
12. Kraus KM, Winter J, Zhang Y, Ahmed M, Combs SE, Wilkens JJ, et al. (2022) Treatment Planning Study for Microbeam Radiotherapy Using Clinical Patient Data. Cancers, 14(3): 685. [DOI:10.3390/cancers14030685] [PMID] []
13. Rich SE, Chow R, Raman S, Liang Zeng K, Lutz S, Lam H, et al. (2018) Update of the systematic review of palliative radiation therapy fractionation for bone metastases. Radiother Oncol. 126(3): 547-557. Erratum in: Radiother Oncol. 2019 Jun; 135:201. [DOI:10.1016/j.radonc.2019.03.023] [PMID]
14. Sit D, Zhao B, Chen KT, Lohrisch C, Olson R, Nichol A, et al. (2022) The Effect of Breast Cancer Subtype on Symptom Improvement Following Palliative Radiotherapy for Bone Metastases. Clinical Oncology (Royal College of Radiologists (Great Britain)), 34(4): 267-273. [DOI:10.1016/j.clon.2021.09.018] [PMID]
15. Pielkenrood BJ, van der Velden JM, van der Linden YM, Bartels MMT, Kasperts N, Verhoeff JJC, et al. (2021) Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort. Int J Radiat Oncol Biol Phys. 110(2): 358-367. [DOI:10.1016/j.ijrobp.2020.11.060] [PMID]



XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 3 (6-2023) Back to browse issues page